Cell Signaling Technology

Phospho-Rev-erb alpha (Ser55/59) Antibody

#2129 · $362

100
Citing papers
30.8k
Combined citations
Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations25HER2/EGFR in Cancer Research15PI3K/AKT/mTOR signaling in cancer15MicroRNA in disease regulation9Fibroblast Growth Factor Research6Cancer-related molecular mechanisms research6Circular RNAs in diseases5Cancer Genomics and Diagnostics4

Papers citing this product

1
<i>ROS1</i> Rearrangements Define a Unique Molecular Class of Lung Cancers
Journal of Clinical Oncology·2012·1.6k cit.·DOI
2
Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma
Cell·2020·811 cit.·DOI
3
Predictive and Prognostic Impact of Epidermal Growth Factor Receptor Mutation in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib
Journal of Clinical Oncology·2005·775 cit.·DOI
4
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring <i>BRAF</i> Mutations
Journal of Clinical Oncology·2011·689 cit.·DOI
5
Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
PLoS Medicine·2005·683 cit.·DOI
6
Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients
Nature Communications·2016·657 cit.·DOI
7
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Blood·2009·641 cit.·DOI
8
Ribosomal protein S6 phosphorylation is a determinant of cell size and glucose homeostasis
Genes & Development·2005·636 cit.·DOI
9
NetPath: a public resource of curated signal transduction pathways
Genome biology·2010·532 cit.·DOI
10
MiR-21 Induced Angiogenesis through AKT and ERK Activation and HIF-1α Expression
PLoS ONE·2011·494 cit.·DOI
Phospho-Rev-erb alpha (Ser55/59) Antibody — Evidence — PubIndex